Colony Group LLC Sells 1,494 Shares of Express Scripts Holding Co (ESRX)
Colony Group LLC trimmed its holdings in Express Scripts Holding Co (NASDAQ:ESRX) by 32.6% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 3,083 shares of the company’s stock after selling 1,494 shares during the quarter. Colony Group LLC’s holdings in Express Scripts were worth $238,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in ESRX. Landaas & Co. WI ADV purchased a new position in shares of Express Scripts in the second quarter worth $102,000. Kaizen Advisory LLC increased its stake in shares of Express Scripts by 147.6% in the second quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock worth $104,000 after buying an additional 800 shares during the period. Wealthcare Advisory Partners LLC increased its stake in shares of Express Scripts by 364.7% in the first quarter. Wealthcare Advisory Partners LLC now owns 1,529 shares of the company’s stock worth $106,000 after buying an additional 1,200 shares during the period. Adviser Investments LLC increased its stake in shares of Express Scripts by 321.9% in the second quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock worth $114,000 after buying an additional 1,130 shares during the period. Finally, Sun Life Financial INC increased its stake in shares of Express Scripts by 758.8% in the second quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock worth $117,000 after buying an additional 1,343 shares during the period. Hedge funds and other institutional investors own 84.73% of the company’s stock.
Shares of Express Scripts stock opened at $91.82 on Monday. The company has a current ratio of 0.71, a quick ratio of 0.59 and a debt-to-equity ratio of 0.69. The firm has a market cap of $50.57 billion, a price-to-earnings ratio of 11.18, a P/E/G ratio of 1.13 and a beta of 1.00. Express Scripts Holding Co has a 12-month low of $55.80 and a 12-month high of $91.88.
Several research analysts recently commented on ESRX shares. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Tuesday, May 22nd. Zacks Investment Research raised shares of Express Scripts from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 26th. Royal Bank of Canada lifted their target price on shares of Express Scripts to $94.00 and gave the stock an “outperform” rating in a research note on Monday, August 27th. William Blair raised shares of Express Scripts from a “market perform” rating to an “outperform” rating in a research note on Wednesday, August 1st. Finally, Robert W. Baird downgraded shares of Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 target price on the stock. in a research note on Friday, July 20th. Three investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $85.58.
In other Express Scripts news, insider Christine Houston sold 12,898 shares of the business’s stock in a transaction on Friday, August 10th. The shares were sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the transaction, the insider now directly owns 110,908 shares of the company’s stock, valued at approximately $9,427,180. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.79% of the stock is currently owned by insiders.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Read More: NASDAQ Stock Market Explained
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.